Rossello Xavier, Bueno Héctor, Pocock Stuart J, Van de Werf Frans, Danchin Nicolas, Annemans Lieven, Medina Jesús, Zeymer Uwe
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
London School of Hygiene and Tropical Medicine, London, UK.
Clin Cardiol. 2019 Jan;42(1):111-119. doi: 10.1002/clc.23116. Epub 2018 Dec 7.
Patients discharged after an acute coronary syndrome (ACS) have substantial risk of recurrent ischemic events or dying.
A difference may exist in risk predictors for all-cause mortality and ischemic events between year 1 and 2 of follow-up post-ACS.
EPICOR (NCT01171404) was a prospective, international, real-world cohort study of consecutive patients hospitalized for ACS within 24 hours of symptom onset and surviving to discharge. Total of 10 568 patients were enrolled (555 hospitals; 20 countries) and followed-up for 2 years. From these, 4943 were admitted with ST-elevation myocardial infarction (STEMI) and 5625 with non-ST-elevation ACS (NSTE-ACS). Potential baseline predictors of major adverse cardiac and cerebrovascular events (MACCE; death, non-fatal myocardial infarction [MI], non-fatal stroke) were evaluated in year 1 and 2 post-discharge.
MACCE incidence per 100 person-years at risk within and after 1 year was 5.3 vs 3.6, primarily death (4.1 vs 2.3), with no significant differences for MI or stroke. Older age, lack of coronary revascularization, raised creatinine, low hemoglobin, previous cardiac disease, previous chronic obstructive pulmonary disease, raised glucose, male sex, and geographic region were risk factors for MACCE in both year 1 and 2. By contrast, low ejection fraction, poorer quality of life, low body mass index (BMI) <20 kg/m , in-hospital cardiac complications, and Killip class lost predictive power after 1 year.
We observed continuous MACCE risk during 2 years of follow-up after discharge for ACS, with greater mortality within the first year. Specific predictors at discharge for events after 1 year could not be identified.
急性冠状动脉综合征(ACS)后出院的患者有发生复发性缺血事件或死亡的重大风险。
ACS后随访第1年和第2年全因死亡率和缺血事件的风险预测因素可能存在差异。
EPICOR(NCT01171404)是一项前瞻性、国际性、真实世界队列研究,纳入症状发作24小时内住院且存活至出院的连续性ACS患者。共纳入10568例患者(555家医院;20个国家),并随访2年。其中,4943例为ST段抬高型心肌梗死(STEMI)患者,5625例为非ST段抬高型ACS(NSTE-ACS)患者。在出院后第1年和第2年评估主要不良心脑血管事件(MACCE;死亡、非致死性心肌梗死[MI]、非致死性卒中)的潜在基线预测因素。
1年内及1年后每100人年的MACCE发生率分别为5.3和3.6,主要为死亡(4.1和2.3),MI或卒中无显著差异。年龄较大、未进行冠状动脉血运重建、肌酐升高、血红蛋白降低、既往有心脏病、既往有慢性阻塞性肺疾病、血糖升高、男性以及地理区域是第1年和第2年MACCE的危险因素。相比之下,射血分数降低、生活质量较差、低体重指数(BMI)<20 kg/m²、院内心脏并发症以及Killip分级在1年后失去预测能力。
我们观察到ACS出院后2年随访期间持续存在MACCE风险,第1年死亡率更高。无法确定出院时1年后事件的特定预测因素。